This week, three Mortgage stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
Biotech Movers: Spectrum, AEterna Among Big Losers
A stopped phase 3 trial grounded AEterna Zentaris and a downshift in guidance kneecapped Spectrum Pharmaceuticals last week. More
5 Tax Breaks for Small Business Owners
If you run your own business, be sure to keep an eye on these five quick and common tax breaks. More
3 Capital Markets Stocks to Buy Now
This week, three Capital Markets stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
10 Stocks With Decades of Dividend Growth
If there's one thing better than a dependable dividend, it's one that keeps growing over the years. These 10 stocks have been upping the ante for decades. More
Google’s Great, But Don’t Count Apple Out
While the divergent paths of Google and Apple stock might help to tell a story of Android dominance, don't bet against the Colossus of Cupertino. More
Pullback Whips Bears Into Unsubstantiated Frenzy
Even if the attack on new highs has temporarily stalled, there is currently no evidence to support a bearish stance. More
